Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response

Jürgen Braun, Xenofon Baraliakos, Joachim Listing, C. Fritz, Rieke Alten, Gerd R Burmester, Andreas Krause, Stefan Schewe, Matthias Schneider, Helge B. D. Sørensen, H. Zeidler, Joachim SieperAnnals 2007 · DOI

BibTeX
@article{braun2007persistent,
  author = {Jürgen Braun and Xenofon Baraliakos and Joachim Listing and C. Fritz and Rieke Alten and Gerd R Burmester and Andreas Krause and Stefan Schewe and Matthias Schneider and Helge B. D. Sørensen and H. Zeidler and Joachim Sieper},
  title = {{Persistent clinical efficacy and safety of anti-tumour necrosis factor α therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response}},
  journal = {Annals},
  year = {2007},
  doi = {10.1136/ard.2007.075879},
}

Loading related content...

Figure